The U.S. Food and Drug Administration (FDA) on Nov. 16 said it is developing a new plan which aims to prevent outbreaks of Cronobacter bacteria in instant baby formula.
In a statement, the agency said it would review and update current guidance and rules regarding the manufacturing of infant powdered formula and is considering whether to establish a dedicated group of investigators to conduct inspections of infant formula.
